Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma

被引：3

作者：

Pasquini, Marcelo C. ^{[1
]}

Le Rademacher, Jennifer ^{[2
]}

Flowers, Christopher ^{[3
]}

Lill, Michael ^{[4
]}

Costa, Luciano J. ^{[5
]}

Shore, Tsiporah B. ^{[6
]}

Vaughan, William ^{[7
]}

Craig, Michael ^{[8
]}

Freytes, Cesar O. ^{[9
,10
]}

Shea, Thomas C. ^{[11
]}

Horwitz, Mitchell E. ^{[12
]}

Fay, Joseph W. ^{[13
]}

Mineishi, Shin ^{[14
]}

Rondelli, Damiano ^{[15
]}

Mason, James ^{[16
]}

Reddy, Vijay ^{[17
]}

Braunschweig, Ira ^{[18
]}

Ai, Weiyun ^{[19
]}

Armstrong, Elizabeth ^{[20
]}

Smith, Angela ^{[20
]}

Zhao, Cathy ^{[20
]}

Elekes, Agnes ^{[20
]}

Carreras, Jeanette ^{[1
]}

Kato, Kazunobu ^{[20
]}

Waller, Edmund K. ^{[3
]}

机构：

[1] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA

[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[3] Emory Univ, Div BMT, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[5] Med Univ S Carolina, Charleston, SC 29425 USA

[6] New York Hosp, Cornell Med Ctr Hematol Oncol, New York, NY 10021 USA

[7] Univ Alabama Birmingham, Bone Marrow Transplantat & Cell Therapy Program, Birmingham, AL USA

[8] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA

[9] South Texas Vet Hlth Care Syst, San Antonio, TX USA

[10] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

[11] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA

[12] Duke Univ, Med Ctr, Dept Med, Adult Stem Cell Transplant Program,Div Cellular T, Durham, NC 27710 USA

[13] Baylor Univ, Med Ctr, Dallas, TX USA

[14] Univ Alabama Birmingham, Bone Marrow Transplantat Program, Birmingham, AL USA

[15] Univ Illinois Hosp & Hlth Sci Syst, Dept Med, Sect Hematol Oncol, Chicago, IL USA

[16] Scripps Clin, La Jolla, CA 92037 USA

[17] Univ Florida, Gainesville, FL USA

[18] Montefiore Med Ctr, Bronx, NY 10467 USA

[19] Univ Calif San Francisco, San Francisco, CA 94143 USA

[20] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2013.12.259

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

232

引用

页码：S162 / S162

页数：1

共 50 条

[1] Comparison of the Tolerability of Busulfan, Cyclophosphamide, Etoposide (BuCyVP) Versus Carmustine, Etoposide, Cytarabine, Melphalan (BEAM) for Autologous Hematopoietic Cell Transplant (AHCT) in Hodgkin Lymphoma
Urban, Theresa A.
Lucena, Mariana
Gaffney, Kelly
Dean, Robert M.
Gerds, Aaron T.
Hamilton, Betty K.
Jagadeesh, Deepa
Kalaycio, Matt E.
Pohlman, Brad
Sobecks, Ronald M.
Hill, Brian T.
Rybicki, Lisa
Majhail, Navneet S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[2] BUSULFAN, CYCLOPHOSPHAMIDE, ETOPOSIDE (BUCYVP) OR CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHELAN (BEAM) FOR CONDITIONING PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH HODGKIN LYMPHOMA (HL)?
Salem, G.
Ruppert, A. S.
Efebera, Y.
Elder, P.
Bingman, A.
Penza, S.
Andritsos, L. A.
Devine, S. M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S246 - S246
[3] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
Grisariu, Sigal
Shapira, Michael Y.
Or, Reuven
Avni, Batia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
[4] Busulfan, cyclophosphamide, etoposide is not superior to carmustine, etoposide, cytarabine, mephalan conditioning prior to autologous stem cell transplantation in patients with Hodgkin's lymphoma and is associated with increased toxicity
Salem, G.
Dunavin, N.
Wei, L.
Elder, P.
Penza, S.
Blum, K.
Porcu, P.
Baiocchi, R.
Jones, J.
Flynn, J.
Andritsos, L.
Devine, S. M.
Christian, B.
Efebera, Y.
BONE MARROW TRANSPLANTATION, 2012, 47 : S84 - S85
[5] Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation
Frankiewicz, Andrzej
Sadus-Wojciechowska, Maria
Najda, Jacek
Czerw, Tomasz
Mendrek, Wlodzimierz
Sobczyk-Kruszelnicka, Malgorzata
Soska, Katarzyna
Ociepa, Malgorzata
Holowiecki, Jerzy
Giebel, Sebastian
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2018, 22 (02): : 113 - 117
[6] BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Versus BEAM (Carmustine, Etoposide, Cytarabine, Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
Wu, Ran
Ma, Liyuan
CELL TRANSPLANTATION, 2023, 32
[7] Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
Lin, Meng
Wu, Xiaolong
Zhang, Lei
Li, Ling
Wang, Xinhua
Fu, Xiaorui
Sun, Zhenchang
Zhang, Xudong
Zhu, Linan
Yu, Hui
Chang, Yu
Nan, Feifei
Yan, Jiaqin
Zhou, Zhiyuan
Shi, Cunzhen
Zhang, Mingzhi
Li, Xin
LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 605 - 612
[8] BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma
Ioanna Sakellari
Eleni Gavriilaki
Stella Bouziana
Varnavas Constantinou
Despina Mallouri
Anna Vardi
Anastasia Marvaki
Ioannis Batsis
Damianos Sotiropoulos
Achilles Anagnostopoulos
Bone Marrow Transplantation, 2019, 54 : 921 - 923
[9] BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma
Sakellari, Ioanna
Gavriilaki, Eleni
Bouziana, Stella
Constantinou, Varnavas
Mallouri, Despina
Vardi, Anna
Marvaki, Anastasia
Batsis, Ioannis
Sotiropoulos, Damianos
Anagnostopoulos, Achilles
BONE MARROW TRANSPLANTATION, 2019, 54 (06) : 921 - 923
[10] Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas
Sakellari, Ioanna
Mallouri, Despoina
Batsis, Ioannis
Apostolou, Chrysa
Konstantinou, Varnavas
Abela, Eleni-Maria
Douka, Vasiliki
Marvaki, Anastasia
Karypidis, Kyriakos
Iskas, Michalis
Baliakas, Panayiotis
Kaloyannidis, Panayotis
Yannaki, Evangelia
Sotiropoulos, Damianos
Kouvatseas, Giorgos
Smias, Christos
Anagnostopoulos, Achilles
LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3071 - 3081

← 1 2 3 4 5 →